GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Krishna Institute of Medical Sciences KIMS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

721.65

-0.19%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹39.05bn

FY2017FY2026

Net income

₹2.41bn

FY2017FY2026

Free cash flow

−₹11.15bn

FY2017FY2026

Shareholders' equity

₹22.47bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹39.05bn₹30.04bn₹24.74bn₹21.68bn₹16.51bn₹13.12bn₹11.23bn₹9.18bn₹6.64bn₹5.67bn
Operating income₹5.19bn₹6.16bn₹5.03bn₹4.89bn₹4.73bn₹3.09bn₹1.81bn₹1.22bn₹1.01bn₹840.2m
Net income₹2.41bn₹3.85bn₹3.10bn₹3.36bn₹3.33bn₹2.01bn₹1.19bn−₹477.7m−₹473.6m₹325.6m
Diluted earnings per share5.759.617.768.438.315.033.15-1.14-1.130.91

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹77.59bn₹57.36bn₹38.52bn₹29.41bn₹19.07bn₹14.36bn₹11.96bn₹11.20bn₹9.58bn₹7.75bn
Cash and short-term investments₹898.0m₹1.02bn₹1.32bn₹1.34bn₹1.90bn₹2.84bn₹426.2m₹102.0m₹113.5m₹84.2m
Total liabilities₹52.00bn₹33.17bn₹17.59bn₹10.03bn₹4.97bn₹5.60bn₹5.84bn₹5.53bn₹10.96bn₹4.41bn
Debt₹42.53bn₹25.57bn₹13.55bn₹6.78bn₹2.57bn₹3.16bn₹3.69bn₹3.36bn₹7.53bn₹2.80bn
Shareholders' equity₹22.47bn₹21.38bn₹18.28bn₹16.70bn₹13.87bn₹8.64bn₹5.98bn₹5.41bn−₹1.58bn₹3.26bn
Shares outstanding420m400m400m399m400m400m378m420m420m358m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹3.13bn₹5.82bn₹5.21bn₹4.32bn₹3.24bn₹3.56bn₹2.02bn₹1.34bn₹784.0m₹511.1m
Capital spending−₹14.28bn−₹10.09bn−₹6.47bn−₹5.75bn−₹1.70bn−₹944.3m−₹519.8m−₹773.5m−₹585.1m−₹1.00bn
Free cash flow−₹11.15bn−₹4.27bn−₹1.26bn−₹1.42bn₹1.54bn₹2.62bn₹1.50bn₹565.5m₹198.9m−₹492.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹11.79bn₹10.75bn₹9.98bn₹9.61bn₹8.72bn₹7.65bn₹7.72bn₹7.77bn
Operating income₹1.23bn₹1.22bn₹1.20bn₹1.38bn₹1.39bn₹1.56bn₹1.43bn₹1.77bn
Net income₹415.0m₹425.0m₹534.0m₹669.0m₹786.0m₹1.02bn₹887.0m₹1.07bn
Diluted earnings per share0.991.011.331.671.962.542.222.69
Cash from operations———₹2.85bn————
Capital spending———−₹7.53bn————
Free cash flow———−₹4.69bn————
Total assets—₹77.59bn—₹66.25bn—₹57.36bn—₹45.79bn
Cash and short-term investments—₹898.0m—₹1.74bn₹1.02bn₹1.02bn₹902.0m₹1.41bn
Debt—₹32.88bn—₹25.34bn—₹19.24bn—₹14.69bn
Shareholders' equity—₹22.47bn—₹22.70bn₹24.19bn₹21.38bn₹22.83bn₹20.02bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.7%24.4%22.5%
Operating income2.0%10.9%21.1%
Net income-10.5%3.7%24.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.4%18.4%20.0%19.0%
Net margin9.1%11.0%12.4%10.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings127.463.677.547.037.256.9
Price to sales7.98.19.77.37.58.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-for-1 split · 13 Sept 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.